ABX-1100

N/A

Report date: 2026/05/13 09:17:27

NME

Base Information

Drug NameABX-1100

Drug Alias NameCD71 specific Centyrin-siRNA conjugateABX-1100

ClassificationBiologics > Protein drugs > Protein-drug conjugateSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionGlycogen synthase 1 inhibitorsRNA interferenceAnti-Transferrin receptor protein 1

TargetsGlycogen synthase 1Transferrin receptor protein 1

Therapy Area/IndicationsGlycogen Storage Disease Type II

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAro Biotherapeutics Co

China Registration ClassN/A

Develop Information

Active CompaniesAro Biotherapeutics Co

Inactive CompaniesN/A

Active IndicationsGlycogen Storage Disease Type II

Inactive IndicationsN/A

Other Information

ATC CodeN/A